- bluebird bio, Inc.

Media Contacts

Jess Rowlands

Head of Corporate Communications

(857) 299-6103

jess.rowlands@bluebirdbio.com

Investor Contacts

Courtney O’Leary

Investor Relations

(978) 621-7347

coleary@bluebirdbio.com

bluebird bio and Federal Realty to Establish Biotech Footprint at Assembly Row

Read more about bluebird bio and Federal Realty to Establish Biotech Footprint at Assembly Row

bluebird bio to Present New Gene Therapy Data at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition

Read more about bluebird bio to Present New Gene Therapy Data at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition

bluebird bio: Transforming the Treatment of Sickle Cell Disease

Read more about bluebird bio: Transforming the Treatment of Sickle Cell Disease

bluebird bio Completes Planned Business Separation

Read more about bluebird bio Completes Planned Business Separation

Najoh Tita-Reid

Najoh Tita-Reid

Director

Andrew Obenshain

Andrew Obenshain

Director

Nick Leschly

Nick Leschly

Director

Lis Leiderman

Lis Leiderman

Director

Financial Expert

bluebird bio Sets Record Date and Distribution Date for Planned Business Separation

Read more about bluebird bio Sets Record Date and Distribution Date for Planned Business Separation

bluebird bio Provides Update on Upcoming Planned Business Separation

Read more about bluebird bio Provides Update on Upcoming Planned Business Separation